Increasing the Infliximab Dose Is Beneficial in Crohn’s Disease Patients Who Responded to a Lower Dose and Relapsed

Publisher： Karger

E-ISSN： 1421-9867|72|2-3|124-128

ISSN： 0012-2823

Source： Digestion, Vol.72, Iss.2-3, 2005-10, pp. : 124-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mucormycosis in a Crohn’s Disease Patient Treated with Infliximab

By  

Digestion, Vol. 80, Iss. 3, 2009-09 ,pp. : 182-184

Karger

Access to resources Recommend Favorite

Successful Treatment of Refractory Duodenal Crohn’s Disease with Infliximab

By Odashima Masaru   Otaka Michiro   Jin Mario   Horikawa Youhei   Matsuhashi Tamostu   Ohba Reina   Koizumi Shigeto   Kinoshita Nobukatsu   Takahashi Taiji   Watanabe Sumio  

Digestive Diseases and Sciences, Vol. 52, Iss. 1, 2007-01 ,pp. : 31-32

Springer Publishing Company

Access to resources Recommend Favorite

Infliximab Therapy for Crohn’s Disease in a Patient with Chronic Hepatitis B

By Ueno Yoshitaka   Tanaka Shinji   Shimamoto Masaru   Miyanaka Yoshihiro   Hiyama Toru   Ito Masanori   Kitadai Yasuhiko   Yoshihara Masaharu   Sumii Masaharu   Chayama Kazuaki  

Digestive Diseases and Sciences, Vol. 50, Iss. 1, 2005-01 ,pp. : 163-166

Springer Publishing Company

Access to resources Recommend Favorite

Infliximab Therapy Improves the Bone Metabolism in Fistulizing Crohn’s Disease

By  

Digestive Diseases, Vol. 24, Iss. 1-2, 2006-05 ,pp. : 201-206

Karger

Access to resources Recommend Favorite

Outcome of Patients with Nonstenotic, Nonfistulizing Crohn’s Disease

By Nos Pilar   Garrigues Vicente   Bastida Guillermo   Maroto Nuria   Ponce Marta   Ponce Julio  

Digestive Diseases and Sciences, Vol. 49, Iss. 11-12, 2004-11 ,pp. : 1771-1776

Springer Publishing Company

Access to resources Recommend Favorite